Company page
Genomed S.a.
Genomed S.a. is a public company listed on the Polish market under the ticker GEN. With a market capitalization of approximately 8.88 million, Genomed focuses on advancements in genomics and biotechnology. The company is dedicated to developing innovative solutions in the field of personalized medicine.
- Ticker
- GEN:NEWCONNECT
- Asset type
- Stock
- Market cap
- $8.9M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NEWCONNECT
- Currency
- PLN